Market revenue in 2023 | USD 171.4 million |
Market revenue in 2030 | USD 394.5 million |
Growth rate | 12.6% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Reagents and Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents and Consumables, Assays, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Charles River Laboratories International Inc, Labcorp Holdings Inc, Eurofins Scientific SE, Jubilant Pharmova, Syngene, Inotiv Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genetic toxicology testing market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 47.9% in 2023. Horizon Databook has segmented the UK genetic toxicology testing market based on reagents and consumables, assays, services covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UK genetic toxicology testing market, including forecasts for subscribers. This country databook contains high-level insights into UK genetic toxicology testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account